Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Bioreactor Controls-III01:22

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Scale-Up Processes01:14

Scale-Up Processes

The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Downstream Processing01:29

Downstream Processing

Downstream processing begins once fermentation is complete and involves a series of steps to recover and purify products such as acids, vitamins, antibiotics, or proteins.Cell HarvestingFor example, for intracellular protein-based products, the first step is harvesting the cells. This is typically achieved using centrifugation or filtration to separate the cells from the liquid phase.Cell Disruption for Intracellular ProductsIf the target product is intracellular, the harvested cells must be...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Developing Micro/Nanostructured Fluidic Mixing Technology for Biomedical Applications.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Hierarchical Micro/Nano-Structured Biomaterials for Wound Healing.

Research (Washington, D.C.)·2025
Same author

Genetically Engineered Stromal Cell Exosomes from High-Throughput Herringbone Microfluidics.

ACS nano·2025
Same author

Glycyrrhizic Acid Hydrogel Microparticles Encapsulated with Mesenchymal Stem Cell Exosomes for Wound Healing.

Research (Washington, D.C.)·2024
Same author

Bioinspired Surfaces Derived from Acoustic Waves for On-Demand Droplet Manipulations.

Research (Washington, D.C.)·2024
Same author

Magnetic photonic crystals for biomedical applications.

Smart medicine·2024

相关实验视频

Updated: Jun 26, 2026

Author Spotlight: Asymmetric Field Flow Fractionation for Bioreactor Integration
06:28

Author Spotlight: Asymmetric Field Flow Fractionation for Bioreactor Integration

Published on: February 2, 2024

898

新兴技术朝着细胞外囊泡大规模生产的方向发展.

Junjie Huang1, Hanxu Chen1, Ning Li1

  • 1Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China.

Bioactive materials
|June 30, 2025
PubMed
概括

研究人员正在探索提高细胞外囊泡 (EVs) 的产生和净化的策略,以治疗应用. 细胞培养和隔离方法的进步旨在克服临床翻译的局限性.

关键词:
生物反应器是一种生物反应器.临床翻译 临床翻译细胞外囊泡中的细胞外囊泡.隔离 隔离 隔离 隔离大规模的大规模.

更多相关视频

Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles
05:36

Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles

Published on: January 26, 2024

1.5K
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

874

相关实验视频

Last Updated: Jun 26, 2026

Author Spotlight: Asymmetric Field Flow Fractionation for Bioreactor Integration
06:28

Author Spotlight: Asymmetric Field Flow Fractionation for Bioreactor Integration

Published on: February 2, 2024

898
Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles
05:36

Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles

Published on: January 26, 2024

1.5K
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

874

科学领域:

  • 生物技术是生物技术.
  • 细胞生物学 细胞生物学
  • 再生医学是一种再生医学.

背景情况:

  • 细胞外囊泡 (EVs) 对于细胞间信号传递至关重要,并具有治疗潜力.
  • 目前的电动汽车生产和隔离方法在产量和可扩展性方面面临挑战.
  • 标准化,可扩展的方法对于EVs的临床应用至关重要.

研究的目的:

  • 审查加强细胞外囊泡 (EV) 生产和净化的策略.
  • 讨论生物反应器方法和替代电气源.
  • 分析传统与先进的隔离技术以及临床翻译挑战.

主要方法:

  • 优化EV生产的细胞产量和培养规模.
  • 探索替代EV来源,包括非哺乳动物生物和人工囊泡.
  • 使用具有受控培养参数,介质和刺激的生物反应器.
  • 将超离心与先进的微流体隔离方法进行比较.

主要成果:

  • 各种策略可以显著提高电动汽车生产产量.
  • 生物反应器技术提供了对EV生物发生的精确控制.
  • 先进的隔离方法提供了比传统技术更好的纯度和可扩展性.
  • 克服生产和净化挑战是临床翻译的关键.

结论:

  • 提高EV的生产和净化对于实现其治疗潜力至关重要.
  • 整合先进技术有望实现大型电动汽车制造.
  • 解决扩展和标准化方面的挑战将加速电动汽车的临床转化.